MannKind Corporation On Thursday January 21, 2016 MannKind Corporation (NASDAQ:MNKD) had announced that it had entered into a license agreement, with a newly …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced the beginning of recruitment for its collaborative vaccine study for MERS (Middle East Respiratory Syndrome). Inovio and GeneOne Life …
Healthcare analysts weighed in today on cancer therapeutics firm Galena Biopharma Inc (NASDAQ:GALE), biopharmaceutical company ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and immunotherapy company Inovio Pharmaceuticals Inc (NASDAQ:INO).
Following the annual J.P.
Following J.P.
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced it has been selected to receive a $500,000 grant from the U.S.
Analysts from Maxim Group and Mizuho Securities weigh in on controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and biotech company Inovio Pharmaceuticals Inc (NASDAQ:INO). …
GeneOne Life Science Inc. announced that the U.
Inovio Pharmaceuticals Inc (NASDAQ:INO) reported financial results for the quarter ended September 30, 2015. Total revenue was $24.
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced an interim data analysis showing that its INO-3112 DNA-based immunotherapy generated specific T-cell responses and was well tolerated in …
